Dynavax Technologies Corp (NASDAQ:DVAX)
| 9.91 BATS BZX Real-Time Price As of 11:21am ET |  +0.03 / +0.30%Today’s Change | 7.26 Today|||52-Week Range 17.48 | -6.86% Year-to-Date |
Latest DVAX News | Press Releases
No recent news for Dynavax Technologies Corp.
Today’s Trading
| Previous close | 9.88 |
| Today’s open | 9.90 |
| Day’s range | 9.82 - 9.95 |
| Volume | 9,420 |
| Average volume (3 months) | 1,604,623 |
| Market cap | $1.3B |
Data as of 11:21am ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | +273.42% |
| Earnings growth (this year) | -123.60% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +65.36% |
| P/E ratio | 5.0 |
| Price/Sales | 2.22 |
| Price/Book | 2.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IOVAIovance Biotherapeut... | +0.62 | +11.21% |
| RCUSArcus Biosciences In... | +0.45 | +2.55% |
| RCKTRocket Pharmaceutica... | +0.10 | +0.60% |
| GERNGeron Corp | 0.00 | 0.00% |
Data as of 11:22am ET, 03/27/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $722.7M |
| Annual profit (last year) | $292.9M |
| Net profit margin | 40.53% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
